Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Non-caloric sweeteners are common food supplements consumed by millions worldwide as means of combating weight gain and diabetes, by retaining sweet taste without increasing caloric intake. While they are considered safe, there is increasing debate regarding their potential role in contributing to metabolic derangements in some humans. The investigators recently demonstrated that non-caloric sweeteners consumption could induce glucose intolerance in mice and, in preliminary experiments, in distinct human subsets, by functionally altering the gut microbiome, and that the gut microbiome plays an important role in mediating differential glucose responses to identical foods. The proportion of the human population that is susceptible to glucose intolerance induced by non-caloric sweeteners, the common factors that are shared between these individuals and whether and how the microbiome promotes the metabolic derangements remain to be addressed.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| glucose | Experimental |
| |
| aspartame | Experimental |
| |
| sucralose | Experimental |
| |
| saccharin | Experimental |
| |
| Stevia | Experimental |
| |
| No supplement control | Experimental |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Glucose | Dietary Supplement | Daily consumption of 5g of glucose, for 14 days. |
| |
| Measure | Description | Time Frame |
|---|---|---|
| Blood glucose level | Continuous glucose monitor device | 28 days |
| Measure | Description | Time Frame |
|---|---|---|
| Microbiome | Stool and oral samples | 28 days |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Eran Elinav | Weizmann Institute of Science | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Weizmann Institute of Science | Rehovot | Israel |
Not provided
| ID | Term |
|---|---|
| D018149 | Glucose Intolerance |
| ID | Term |
|---|---|
| D006943 | Hyperglycemia |
| D044882 | Glucose Metabolism Disorders |
| D008659 | Metabolic Diseases |
| D009750 | Nutritional and Metabolic Diseases |
Not provided
Not provided
| ID | Term |
|---|---|
| D005947 | Glucose |
| D001218 | Aspartame |
| C026285 | trichlorosucrose |
| D012439 | Saccharin |
| C012043 | stevioside |
| ID | Term |
|---|---|
| D006601 | Hexoses |
| D009005 | Monosaccharides |
| D000073893 | Sugars |
| D002241 | Carbohydrates |
| D004151 |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Aspartame |
| Dietary Supplement |
Daily consumption of six commercially available sachets containing aspartame and glucose as bulking agent (1g each sachet), for 14 days. |
|
| Sucralose | Dietary Supplement | Daily consumption of six commercially available sachets containing sucralose and glucose as bulking agent (1g each sachet), for 14 days. |
|
| Saccharin | Dietary Supplement | Daily consumption of six commercially available sachets containing saccharine and glucose as bulking agent (1g each sachet), for 14 days. |
|
| Stevia | Dietary Supplement | Daily consumption of six commercially available sachets containing Stevia and glucose as bulking agent (1g each sachet), for 14 days. |
|
| No Supplement | Other | Follow up without any dietary supplementation. |
|
| Dipeptides |
| D009842 | Oligopeptides |
| D010455 | Peptides |
| D000602 | Amino Acids, Peptides, and Proteins |
| D013844 | Thiazoles |
| D013457 | Sulfur Compounds |
| D009930 | Organic Chemicals |
| D052160 | Benzothiazoles |
| D001393 | Azoles |
| D006573 | Heterocyclic Compounds, 1-Ring |
| D006571 | Heterocyclic Compounds |
| D006574 | Heterocyclic Compounds, 2-Ring |
| D000072471 | Heterocyclic Compounds, Fused-Ring |